Agilent appoints Adam Elinoff as chief financial officer

Agilent Technologies Inc. (NYSE: A) announced the appointment of Adam S. Elinoff as chief financial officer, effective November 17.

Elinoff brings two decades of financial experience in corporate finance, investor relations, strategy and business transformation. He joins Agilent from Amgen, where he spent 19 years in various finance, strategy and transformation leadership roles, most recently serving as vice president of finance and treasurer.

At Amgen, Elinoff previously served as regional CFO for Europe, the Middle East, Africa, Latin America, and Canada, overseeing finance and analytics teams across 67 markets and managing a $6 billion profit and loss statement. During his tenure, he established the Amgen Capability Center in Portugal and held leadership roles in corporate financial planning and analysis, global business services, corporate strategy, and research and development finance.

"Adam's expertise in strategic planning and M&A and his commitment to cross-functional collaboration will be invaluable as we accelerate Agilent's Ignite Operating System," said Padraig McDonnell, Agilent president and CEO.

Before joining Amgen, Elinoff held finance leadership positions at Shire Pharmaceuticals and International Rectifier. He began his career as a small-enterprise-development volunteer with the Peace Corps in Senegal, where he established microcredit programs for entrepreneurs.

Elinoff holds a Bachelor of Arts in Economics from Hamilton College and an MBA from Arizona State University's W. P. Carey School of Business.

McDonnell also thanked Rodney Gonsalves for his service as interim chief financial officer. Gonsalves will continue in his role as corporate controller and principal accounting officer.

Agilent reported revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide, according to the press release.

You May Also Be Interested In

• Agilent (A) PT Raised to $150 at Jefferies
• Nu Skin EVP of global sales takes medical leave
• Baxter names John Rogers as CFO, effective October 2026